Market revenue in 2023 | USD 503.1 million |
Market revenue in 2030 | USD 625.1 million |
Growth rate | 3.1% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.34% in 2023. Horizon Databook has segmented the U.S. in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of targeted diseases such as cancer, infectious diseases, and cardiovascular diseases, among others, is increasing the demand for testing solutions, which is further driving the IVD quality control market.
According to the American Cancer Society’s estimates, in 2022, around 1.9 million new cases of cancer are estimated to be diagnosed in the U.S., which is expected to lead to around 609,360 deaths. In addition, during the COVID‐19 outbreak, several U.S.-based companies were involved in extensive R&D of novel diagnostic tests.
Thus, there is a high demand for quality control in diagnostics. The presence of leading market players, such as Siemens Healthineers AG; Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific Inc; and QuidelOrtho Corporation; is also a key driver of the market in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into U.S. in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account